MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1816510

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19.

Budnevsky Andrey V, Avdeev Sergey N, Arkhipova Ekaterina D, Kosanovic Djuro, Shishkina Viktoria V, Chernik Tatiana A, Ovsyannikov Evgeniy S, Perveeva Inna M, Filin Andrey A, Tokmachev Roman E, Pertsev Alexander V, Ivanova Elena E, Samoylenko Tatiana V, Antakova Lyubov N

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Acute myocardial injury is a frequent and severe complication of COVID-19, contributing to increased mortality. This study investigates the role of chymase-positive mast cells (MCs) in myocardial damage among patients who died from severe or critical COVID-19.

METHODS

Cardiac tissue samples from 60 deceased patients were analyzed histologically and immunohistochemically to assess MC density, degranulation status, and associated fibrotic remodeling. Clinical and laboratory parameters, including troponin I levels and inflammatory markers were obtained during hospitalization period.

RESULTS

The findings revealed a low overall density of cardiac MCs, with a predominance of degranulated chymase-positive cells. These MCs were significantly correlated with indicators of severe COVID-19 progression, such as neutrophilic leukocytosis, elevated band neutrophils, monocytosis, and increased erythrocyte sedimentation rate. A strong association was also observed between chymase-positive MCs and elevated troponin I levels, the association between troponin I and degranulating chymase-positive MC density remained statistically significant after multivariable adjustment, supporting an independent link to myocardial injury. Additionally, increased MC presence coincided with extensive interstitial and perivascular fibrosis, marked by a predominance of type III collagen.

CONCLUSIONS

These results support the hypothesis that chymase-positive MCs contribute to myocardial inflammation and fibrosis in the context of COVID-19. Understanding their role may open avenues for targeted therapies aimed at mitigating cardiac complications in future coronavirus-related diseases.

Для цитирования: Budnevsky Andrey V, Avdeev Sergey N, Arkhipova Ekaterina D, Kosanovic Djuro, Shishkina Viktoria V, Chernik Tatiana A, Ovsyannikov Evgeniy S, Perveeva Inna M, Filin Andrey A, Tokmachev Roman E, Pertsev Alexander V, Ivanova Elena E, Samoylenko Tatiana V, Antakova Lyubov N. Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1816510.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.